Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease
出版年份 2018 全文链接
标题
Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease
作者
关键词
-
出版物
JOURNAL OF ALZHEIMERS DISEASE
Volume 62, Issue 4, Pages 1857-1863
出版商
IOS Press
发表日期
2018-03-28
DOI
10.3233/jad-170784
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biosensing utilizing magnetic markers and superconducting quantum interference devices
- (2017) Keiji Enpuku et al. SUPERCONDUCTOR SCIENCE & TECHNOLOGY
- Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
- (2017) Lih-Fen Lue et al. Frontiers in Aging Neuroscience
- BACE1 Activity in Cerebrospinal Fluid and Its Relation to Markers of AD Pathology
- (2017) Sandra D. Mulder et al. JOURNAL OF ALZHEIMERS DISEASE
- A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1–42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics
- (2016) Linan Song et al. Alzheimers Research & Therapy
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Amyloid-β efflux from the central nervous system into the plasma
- (2014) Kaleigh Filisa Roberts et al. ANNALS OF NEUROLOGY
- Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid- in Cerebrospinal Fluid
- (2014) A. Leinenbach et al. CLINICAL CHEMISTRY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- The amyloid-β degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease
- (2014) Josef Pannee et al. NEUROSCIENCE LETTERS
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
- (2013) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- Developing novel blood-based biomarkers for Alzheimer's disease
- (2013) Heather M. Snyder et al. Alzheimers & Dementia
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer's Disease
- (2012) M.J. Chiu et al. Current Alzheimer Research
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biofunctionalized Magnetic Nanoparticles for Specifically Detecting Biomarkers of Alzheimer’s Disease in Vitro
- (2011) Che-Chuan Yang et al. ACS Chemical Neuroscience
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started